Wyden showdown at hand

Wyden showdown at hand

Scripps, NIH ready to discuss technology transfer deals

WASHINGTON - Testimony by NIH Director Bernadine Healy and representatives of The Scripps Research Institute and Sandoz Pharmaceuticals Corp. will culminate several weeks of harried investigation on Thursday as Rep. Ron Wyden launches a new round of hearings on whether the federal government should impose price restraints on companies that enter into partnerships with federally supported research institutions.

"This hearing is part of an inquiry into the character and result of relationships involving exclusive transfer of technology between private, tax-exempt, non-profit research

Read the full 968 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE